Baidu
map

Clinical Nutrition:多喝低脂或脱脂牛奶可降低全因和心脏特异性死亡率

2021-10-06 MedSci原创 MedSci原创

随着人们对营养认知的加深,也逐步了解了热量的计算,明白了脂肪是热量来源的一大主力。

      随着人们对营养认知的加深,也逐步了解了热量的计算,明白了脂肪是热量来源的一大主力。于是在超市中,我们也可以看到低脂牛奶、脱脂酸奶等更为“健康”的食物。但目前对于日常生活中究竟是该喝全脂牛奶好还是喝低脂牛奶较好都还没有定论。本研究旨在探究与全脂牛奶相比,总死亡率和病因特异性死亡率与 2g/100ml 或≤ 1g/100ml 低脂牛奶消费量之间的关联。

 

      研究人员在1999-2014年间在美国国家健康和营养检查项目中招募了 29283 名年龄≥20 岁的成年人,然后随访了平均8.3 年。在随访期间收集了患者们基线时的牛奶消费类型(例如,全脂、2g/100ml 低脂和≤1g/100ml 低脂)。使用加权 Cox 比例回归评估牛奶类型和死亡率之间关联的危险比。

 

      在 241572 人年的随访时间中,发生了4170例死亡事件,包括730例心脏病相关死亡和 846例癌症死亡。经多变量调整后,摄入脂肪含量较低的牛奶与总死亡率和血管死亡率呈负相关关系。与食用全脂牛奶的参与者相比,食用2克/100克或≤1克/100克低脂牛奶的参与者的总死亡率降低了14%–22%(p≤0.001)。摄入2g/100ml 或≤ 1g/100ml低脂牛奶的个体心脏相关死亡率的风险比 (95% CI) 为 0.73 (0.55–0.97) 和 0.67 (0.49–0.91)(p= 0.009))。在癌症、阿尔茨海默病或糖尿病导致的死亡率方面,全脂牛奶和低脂牛奶之间没有发现显着差异。

 

      本项研究证实与全脂牛奶相比,低脂或脱脂牛奶的摄入与总死亡率和心脏相关死亡率的降低有关。低脂牛奶可能比全脂牛奶更有利于促进普通成年人的心血管健康。

 

 

原始出处 :

Shanjie Wang. Et al. Decreased risk of all-cause and heart-specific mortality is associated with low-fat or skimmed milk consumption compared with whole milk intake. Clinical Nutrition.2021.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1899515, encodeId=714a189951540, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Jul 08 14:50:22 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217563, encodeId=2e29121e563d4, content=<a href='/topic/show?id=3ea66e753d1' target=_blank style='color:#2F92EE;'>#牛奶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67753, encryptionId=3ea66e753d1, topicName=牛奶)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat May 07 10:18:30 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661662, encodeId=07bc166166265, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Tue Jul 26 02:50:22 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507794, encodeId=852a150e794b2, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Oct 08 12:50:22 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1899515, encodeId=714a189951540, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Jul 08 14:50:22 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217563, encodeId=2e29121e563d4, content=<a href='/topic/show?id=3ea66e753d1' target=_blank style='color:#2F92EE;'>#牛奶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67753, encryptionId=3ea66e753d1, topicName=牛奶)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat May 07 10:18:30 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661662, encodeId=07bc166166265, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Tue Jul 26 02:50:22 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507794, encodeId=852a150e794b2, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Oct 08 12:50:22 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1899515, encodeId=714a189951540, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Jul 08 14:50:22 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217563, encodeId=2e29121e563d4, content=<a href='/topic/show?id=3ea66e753d1' target=_blank style='color:#2F92EE;'>#牛奶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67753, encryptionId=3ea66e753d1, topicName=牛奶)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat May 07 10:18:30 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661662, encodeId=07bc166166265, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Tue Jul 26 02:50:22 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507794, encodeId=852a150e794b2, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Oct 08 12:50:22 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1899515, encodeId=714a189951540, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Jul 08 14:50:22 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217563, encodeId=2e29121e563d4, content=<a href='/topic/show?id=3ea66e753d1' target=_blank style='color:#2F92EE;'>#牛奶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67753, encryptionId=3ea66e753d1, topicName=牛奶)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat May 07 10:18:30 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661662, encodeId=07bc166166265, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Tue Jul 26 02:50:22 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507794, encodeId=852a150e794b2, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Fri Oct 08 12:50:22 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-08 zll0628

相关资讯

阿司匹林或将癌症患者的死亡风险降低 20%

在对约 250,000 名癌症患者(包含18种癌症)的治疗方案中服用阿司匹林,死亡风险降低 20%

JACC:年轻的心脏病女医生更容易遭受歧视和性骚扰!

年轻的心脏病女医生更容易遭受歧视和性骚扰

2021 ESC:预防TAVR房颤患者心脏病发作或中风,艾多沙班不劣于维生素 K 拮抗剂

8月28日,ESC大会公布了ENVISAGE-TAVI AF最新研究结果。ENVISAGE-TAVI AF研究是一项跨国、多中心、随机、开放标签、盲法终点评估对照研究,探索房颤患者经导管主动脉瓣植入术

JAHA:心脏病女性妊娠后的长期心血管疾病结局

妊娠后,患有心脏病的妇女长期心血管不良结局的风险很高。当前的妊娠风险预测工具可以确定长期心血管事件风险最高的妇女。

梅斯心血管疾病进展 (006期)

编者按:梅斯医学将定期进行汇总,帮助大家概览心血管领域最新进展。下面是呈现给大家的最新一期的心血管进展。enjoy~

Baidu
map
Baidu
map
Baidu
map